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Abstract 
This project stems from the desire to explore and eventually harness the enzymatic mechanism of 
4-(hydroxymethyl)-2-furan-carboxaldehyde-phosphate synthase (MfnB). The enzyme of interest, 
MfnB, is found most prominently in methanogens and some bacteria and can catalyze five or 
more separate chemical transformations in a single active site. This singular enzyme takes two 
molecules of glyceraldehyde-3-phosphate and creates a furan-containing compound, 4-
(hydroxymethyl)-2-furan-carboxaldehyde-phosphate (4-HMF-P). Furan-containing compounds 
have been highlighted for their high potential in the production of biofuels and biomaterial 
compounds; thus, research efforts seek to create a more efficient synthesis process for furan 
compounds. The broad industrial applications of MfnB could usher in a new era for the synthesis 
of furan compounds to be used in the generation of liquid fuel or other valuable biomaterials via 
enzyme-catalyzed reactions. Despite the initial characterization of MfnB and the identification of 
Schiff base-forming lysine, the detailed mechanism of MfnB remains speculative. Our team 
seeks to understand the details of the catalytic mechanism utilizing a site-directed mutagenesis, 
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In an attempt to focus research efforts for chemical opportunities from biorefinery 
carbohydrates, the Department of Energy (DOE) released a “Top 10 + 4” list of the most 
promising platform chemicals.1 A platform chemical is a versatile molecule that can be 
chemically converted into a variety of value-added chemicals. Platform chemicals are crucial to 
the biorefinery concept which is an industrial term used to describe the conversion of biomass 
into various valuable chemicals through a variety of chemical transformations.  
 
Figure 1. Outline of the biorefinery concept. 
Economically speaking, platform chemicals are crucial to the success of biorefinery. If 
one compound can be converted into numerous compounds, the conversion process will be much 
more efficient and profitable than if a variety of compounds were to needed to produce a variety 
of products. The platform chemical makes the industrial conversion of biomass to valuable 
chemicals much more streamlined. The DOE list identifies underdeveloped target molecules 
which have potential to be used as platform molecules in an attempt to catalyze research focused 
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specifically on these molecules which could turn profit and thus make the research efforts a 
worthy investment. 
 Working at the intersection of biology and chemistry, this research focuses efforts on 
2,4-hydroxymethylfurfural (2,4-HMF) derivatives and their potential to be used as a platform 
and precursor molecule. Furan-containing compounds were left off the original DOE list due to 
problems with yields and selective conversion processes but were added to the list when it was 
revised in 2010 as methods for the dehydration of sugars to furans had greatly improved.2 The 
specific benefit of 2,4-HMF is that it functions as a precursor molecule to a variety of value-
added chemicals including a biofuel (2,4-dimethylfuran), liquid crystals (2,4-furandicarboxylic 
acid), crosslinking copolymers (EOEFCA ), and pharmaceutical products (2,4-
bis(hydroxymethyl)furan).  
 
Figure 2. Chemical structures of platform molecule 2,4-HMF and its valuable conversion 
products. 
 
Due to the resonance of the furan ring, the 2,4-HMF isomer is more difficult to 
synthesize than the 2,5-isomer which limits its viability for large-scale production process. The 
current method utilizes organic synthesis which uses harsh conditions and results in problems 
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with selectivity. On the industrial level, glycerol is converted to glyceraldehyde (GLYD) or 
dihydroxyacetone (DHA) through a selective biocatalyzed or metal-catalyzed oxidation 
respectively.4-5 A base catalyzed condensation then converts GLYD and DHA to a ketohexose 
and an acid catalyzed dehydration reaction then converts the ketohexose to a final mixture of 5- 
and 4-HMF (Figure 3).6 
  
Figure 3. Current organic synthesis pathway for isomeric mixture of HMF. 
It has been demonstrated that DHA condensed with DHA produces the 4- isomer while 
DHA condensed with GLYD produces the 5- isomer meaning that the batch method produces an 
isomeric mixture of HMF.  As the 4- isomer is desired as the precursor to numerous valuable 
chemicals, the low selectivity of the current synthetic method poses a problem for industrial use. 
As an alternative to the current organic synthesis methods, this research presents a potential 
biochemical approach to synthesize 2,4-HMF and its derivatives. A recently discovered and 
novel enzyme, 4-(Hydroxymethyl)-2-furancarboxaldehyde-phosphate synthase (MfnB), has 
potential to be used in the biochemical synthesis of 2,4-HMF. 
Novel enzyme MfnB was discovered in 2014 when it was isolated from the 
methanogenic archaebacteria, Methanocaldococcus jannaschii.7 Methanogens partake in a 
biological process known as methanogenesis to produce methane gas from carbon dioxide 
through metabolic processes. In the methanogenesis pathway, methanofuran is a coenzyme 
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necessary for the reduction of carbon dioxide to methane. Enzyme MfnB exists as the first step 
in the synthesis of methanofuran within the metabolic processes of M. jannaschii where  MfnB 





Figure 4. The first step in the biosynthetic pathway of methanofuran in M. jannaschii. 
 Previous study has elucidated that MfnB functions using a single active site but takes the 
molecules of Ga3P through a series of chemical transformations including dephosphorylation, 
isomerization, aldol condensation, cyclization, and dehydration (Figure 5).7 This reaction scheme 
makes MfnB unique in that it performs five separate chemical reactions using one active site 
where typical enzymes perform only one reaction; however, the detailed mechanism of the 
reactions taking place at the active site is still unknown. This gap in knowledge is due to the 
difficulty in identification of the catalytic intermediates of the reaction. Currently, the wild-type 
MfnB has been successfully crystallized; however, there is no structural evidence with respect to 
the catalytic intermediates. Due to the activity of the conversion of substrate to product in the 
wild-enzyme, it is very difficult for co-crystallization of the catalytic intermediates in the active 
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site. Thus, one aim of this project is to generate mutant enzymes with limited of no activity in 
hopes that trapping the catalytic intermediates will become possible. 
 
 
Figure 5. Proposed mechanism for the catalytic activity of enzyme MfnB. 
 
As shown above, the two molecules of Ga3P bind at two binding sites within the active 
site of the enzyme. Mass spectrometry studies have shown that at binding site I, lysine 27 forms 
a Schiff base with the triose sugar allowing for a dephosphorylation reaction to occur.8 Although 
the role of one amino acid residue in this complex mechanism is known, there is no evidence to 
support how the other reaction steps are catalyzed within the active site. 
2 
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 The defining step in this series of reactions is the aldol condensation reaction which 
catalyzes a new C-C bond and turns the two 3 carbon molecules into one 6 carbon molecule. 
Upon comparison with the enzyme deoxyribose-5-phosphate aldolase (DERA), a class 1 aldolase 
that is also able to catalyze an aldol condensation reaction, no distinct tertiary structural 
deviations were evident.8  
 
Figure 6. Structural comparison of MfnB (left) and Class I aldolase DERA (right). 
 
Both enzymes have an α/β barrel (TIM) structure and both active sites shared four 
conserved amino acids: Two aspartic acid residues and two lysine residues (Figure 6).8 Because 
the structure-function relationship for enzymes is so strong, the stark structural similarities 
between the enzymes indicates that their functions should also be very similar; however, DERA
can catalyze only one reaction, an aldol condensation, while MfnB can catalyze five distinct 
chemical transformations. 
To probe the active site of MfnB, generate mutant enzymes with limited and/or no 
catalytic activity, and ultimately determine a detailed catalytic mechanism, a site-directed 
mutagenesis method combined with a kinetic study of the mutant enzymes was used. After 
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structural evaluation of the MfnB active site along with a sequence alignment, a set of 14 
residues residing at or near the active site were chosen for mutation. The sequence alignment was 
used to track the evolutionary history of enzyme MfnB. Residues which are strictly or highly 
conserved within the enzyme structure have a high likelihood of being catalytically important as 
they have not been changed throughout evolution. As the goal of this study is to determine which 
amino acids are catalytically important and thus generate a detailed mechanism, it follows that 
by changing amino acids deemed to be catalytically important it would be expected the mutant 
enzyme would have no activity. This means that mutants with no or very limited activity are of 
interest as this limited activity signifies the enzyme cannot function in their absence thus 
implicating them in the catalytic mechanism.  
By designing a primer to carry the mutation, the amino acid sequence can be changed 
using polymerase chain reaction (PCR). Primers for use in PCR are typically designed in a way 
so that the DNA sequence is complementary to the desired binding site.9 This ensures specific 
binding and results in replication of the desired DNA sequence. The process of site-directed 
mutagenesis utilizes primers that have been designed to carry a mutation where the point of 
mutation will not bind to the existing DNA sequence while the rest of the primer sequence 
exhibits complementarity so base pairing can occur. The DNA can then be replicated through the 
first round of PCR. When the DNA denatures to begin the second cycle, the daughter strand will 
contain the mutation which is then propagated by replication through approximately 30 PCR 
cycles. At the end of the process, the majority of the DNA population contains the desired 
mutation, and the remaining parent DNA can be easily degraded through enzyme digestion.  
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Figure 7. Site-directed mutagenesis converting a serine residue to an alanine residue. Base pairs 
in blue signify the desired mutation point, and base pairs in red show the inherent mismatch of 
the mutagenesis process. 
The mutations are then confirmed through sequencing. Once confirmed, the target mutant 
enzyme is recombinantly expressed on a large scale, purified, and quantified. A kinetics study 
was then conducted using Michaelis-Menten enzyme kinetics to determine the turnover number 
(kcat) and Michaelis constant KM which in turn allowed for calculation of catalytic activity (kcat/ 
KM).  
In this experiment, UV/vis spectroscopy was used to track the progress of the reaction as 
the substrate does not exhibit UV/vis absorbance; however, the product does exhibit absorbance 
at 280 nm. The velocity of reaction was determined for each mutant enzyme at a variety of 
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substrate concentrations, and consequently, Vmax was determined. The catalytic activity can then 
be calculated and compared for each mutant enzyme. In theory, the activity of the mutant should 
correlate directly to the importance of the original amino acid residue in the enzymatic 
mechanism giving clues as to which amino acids are catalytically important. 
Thinking in a broader context, there is potential to construct an in vitro pathway where 
enzyme MfnB is paired directly with the first 4 enzymes of glycolysis to convert glucose, a 
readily available feedstock, into 4,HMF-P, a valuable precursor to a platform molecule. This 
single-pot synthesis would have broad implications in the field of biorefinery in that it would 
offer an efficient biochemical synthesis for a valuable platform molecule. Additionally, as the 
research is being conducted at an undergraduate teaching institute, there is potential for 
classroom development in that this project can be adapted for a classroom laboratory setting 
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For simplicity, this study was divided into two main categories: molecular biology and 
enzymology. Both sections were composed of a variety of individual processes outlined below in 
Figure 8. 
 
Figure 8. The general workflow of the experimental methods. 
 
The two categories had distinct goals with molecular biology being used to introduce a mutation 
to the amino acid of interest and enzymology to characterize the generated mutant. 




The amino acid sequence for protein MfnB was obtained from the Protein Data Bank (PDB) and 
aligned to a variety of homologous enzymes from the same protein family. Amino acids that 
were strictly or highly conserved throughout the alignment were noted for further exploration as 
conservation is indicative of evolutionary importance. Traditionally, if a residue does not change 
throughout the evolutionary history of the enzyme, then the residue has a high chance of being 
implicated in the catalytic mechanism. The amino acid resides chosen for mutation were as 
follows: serine-6 (Ser 6/S6), aspartate-25 (Asp25/D25), lysine-27 (Lys27/K27), serine-33 
Page | 17  
 
(Ser33/S33), serine-56 (Ser56/S56), tyrosine-83 (Tyr83,Y83), lysine-85 (Lys85/K85) , 
methionine-149 (Met149/M149), aspartate-151 (Asp151/D151), lysine-155 (Lys155/K155), 
serine-188 (Ser188/S188), arginine-217 (Arg-217/R217, aspartate-216-arginine-217-asparagine-
218 (∆216-218) for a total of 14 potential mutants. These residues were chosen specifically 
because they are both highly conserved and at or near the active site of MfnB meaning they 
could be important for catalysis. The active site of enzyme MfnB is shown below. 
 
Figure 9. Active site of enzyme MfnB. Active site residues chosen for mutation are highlighted. 
 
Primer Design 
To introduce mutations to the amino acids of interest, primer pairs were designed for use in 
polymerase chain reaction (PCR). Typically, point mutations were introduced; however, in some 
cases, more than one base pair was changed in order to introduce a restriction site for mutation 
detection. A palindromic sequence was introduced near the mutation which is used for detection 
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of the mutation via restriction digest. A primer is a piece of DNA sequence between 25 and 35 
nucleotides. The primer length and annealing temperature are both optimized to provide specific
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binding to the template DNA. The length is optimized as a shorter primer would share sequence 
similarity with many portions of the parent DNA while a longer primer has a higher chance of 
internal complementarity resulting in self-binding. The annealing temperature is near the middle 
of a temperature range that has been optimized for the pfu polymerase (55°C-80°C). The 
program A Protein Editor (APE) was used to check primer design and ensure that any changes 
made to the nucleotide sequence did not affect the phenotype displayed by the enzyme in any 
place other than the desired mutation. The table of all primers designed can be found in 
Supplemental Information Figure S1.  
  
Primer Preparation 
Primers were synthesized from Invitrogen and received in a lyophilized form. Primer tubes were 
spun down at high speed using a table top centrifuge, and 100 µL deionized, autoclaved H2O was 
added to each tube. Primers were then diluted using 2 µL of primer and 118 µL deionized, sterile 
H2O. It was then necessary to take an absorbance measurement to determine the concentration of 
the primers. They were then diluted accordingly to achieve a working concentration of 100 
ng/µL.  
   
Polymerase Chain Reaction 
PCR was carried out at a total volume of 50 µL. To a sterile, dome-capped, PCR tube, the 
following was added: 40 µL deionized, sterile H2O, 5.0 µL 10x pfu buffer, 1.0 µL 10mM 
deoxynucleotide triphosphates (dNTPs), 1 µL pfu polymerase, 1.0 µL plasmid DNA templatea, 
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1.0 µL forward primer, 1.0 µL reverse primer with the primers used carrying the desired 
mutation for each individual reaction. A negative control was also included using the same 
reagents listed above leaving out the pfu polymerase. 
The following parameters were used for the thermal cycler: 
 
Step Temperature (°C) Time (min) 
1 95 2 
2 Melting 95 0.5 
3 Annealing 61 0.5 
4 Extension 72 6 
Repeat back to step 2 for 30 cycles 
5 72 10 
6 4 Hold 
After PCR, the products were run out on a 1% agarose gel to confirm the reaction was successful 
as described below.  
 
Gel Electrophoresis 
A mass of 0.50 g agarose was added to 50 mL 1X TAE (tris base, acetic acid, 
ethylenediaminetetraacetic acid) buffer and microwaved for approximately one minute to 
completely solubilize. The solution was then poured into a gel casting mold, a comb was 
inserted, and was allowed to solidify forming a 1% agarose gel. After solidification, the gel was 
transferred to a running chamber and submerged in 1X TAE buffer. The comb was removed. A 
volume of 2 µL loading dye was mixed with 10 µL PCR product and loaded into the wells of the 
gel. The running chamber was connected to a power supply and the gel was run at 120V for one 
hour. To visualize the DNA, the gel was soaked in a bath of ethidium bromide and visualized 
using UV light. 
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DpnI Digestion 
To degrade the parent DNA, which does not carry the desired mutation, enzyme DpnI was used 
for digestion. DpnI was used specifically because it only degrades methylated DNA which 
makes it specific for the parent DNA as methylation is a post-translational modification not 
introduced during the PCR process. After PCR, 1 µL enzyme DpnI was added to each reaction 
tube to digest any methylated DNA, ensuring that only DNA with the desired mutation was 
remaining. The tubes were incubated at 37 °C for one hour. 
 
Ligation 
The resulting PCR product is linear; however, plasmid DNA should be circular in order to be 
taken up and expressed by the E. coli cells. Ligation, using the enzyme ligase, is used to 
circularize the PCR product. The following reagents were added to a sterile microcentrifuge 
tube: 
Component Each reaction 
Distilled Water (Sterile) 3 μl 
DNA from PCR 5 μl 
T4 Ligase 1 μl 
10 × T4 ligase buffer 1 μl 
Total 10 μl 
The tubes were then incubated for two hours at room temperature. After ligation it was important 
to proceed directly to transformation for best reaction efficiency. 
 
Transformation 
In order to introduce exogenous DNA, in this case the plasmid DNA carrying the desired 
mutation, to host cells for replication, the process of transformation was used.  Sterile 
microcentrifuge tubes were chilled on ice. Supercompetent XL1-Blue (purchased from Agilent) 
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cells were thawed on ice, resuspended, and 50 μL aliquoted into each pre-chilled tube. A volume 
of 2 μL ligation product was added to each tube and allowed to incubate with the cells for 20 
minutes on ice. The cells were heat-shocked at 42 °C for 40 seconds and immediately allowed to 
recover in the ice bath for 2 minutes. Then, 500 μL pre-warmed super optimal broth with 
catabolite repression (SOC) medium was added to each tube and the cells were incubated at 
37°C for one hour with shaking at 250 rmp. Cells were spun-down using a high-speed centrifuge, 
approximately 300 μL SOC was removed, the cells were resuspended, and plated on LB agar 




After successful transformation, colonies were transferred to liquid culture for growth and 
proliferation. A sterile test tube was filled with 2 mL sterile LB broth and 2 μL KAN. Colonies 
were picked from LB agar plates and placed into LB solution. The tubes were incubated 
overnight at 37°C with shaking at 250 rmp. 
 
Plasmid Purification  
To extract the plasmid DNA, a Quiagen Miniprep Kit was used. All buffers are pre-made, and 
the buffer compositions can be found in Table S2. The 2 mL cultures were transferred to a sterile 
microcentrifuge tube and spun down at 13,000 rpm for 3 minutes with a pellet forming at the 
bottom of the tube. The supernatant LB was poured off and each pellet was resuspended in 250 
μL buffer P1. A volume of 250 μL buffer P2 was added to each tube and then gently inverted 5 
times. A volume of 350 μL buffer N3 was added to each tube and gently inverted 5 times. The 
tubes were then spun-down at 13,000 rpm for 10 minutes. The supernatant was transferred to a 
miniprep column, and the columns were centrifuge are 13,000 rpm for one minute. The column 
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was washed with a volume of 750 μL buffer EB and centrifuged at 13,000 rpm for two minutes 
with the flow through being discarded after each minute. The miniprep column was transferred 
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To determine if the mutation had been successfully introduced, a restriction digest was used. The 
following reagents were mixed in a microcentrifuge tube: 
 
Cutsmart Buffer 1 µL 
Enzyme of Choiceb 1 µL 
H2O 3 
Plasmid DNA 5 µL 
 
The tubes were then incubated at 37 °C for one hour. The resulting solutions were run out on a 
1% agarose gel as described above. This process was used to check if a mutation was 
successfully introduced to the plasmid DNA. 
Sequencing 
All samples confirmed through restriction digest were sent to the DNA Facility at Iowa State 
University for sequencing. If the correct mutations were confirmed through sequencing, the 
plasmid was then transformed to supercompetent BL21-DE3 (purchased from Agilent) 
expression cells. If the mutation was not confirmed through sequencing, new colonies were 
picked from the transformation plates. 













Transformation of Expression Host 
Sterile microcentrifuge tubes were chilled on ice. Supercompetent BL21-DE3 cells were thawed 
on ice, resuspended, and 50 μL aliquoted into each pre-chilled tube. A volume of 1 μL plasmid 
carrying desired mutant MfnB was added to each tube and allowed to incubate with the cells for 
20 minutes on ice. The cells were heat-shocked at 42 °C for 20 seconds and immediately allowed 
to recover in the ice bath for 2 minutes. Then, 500 μL pre-warmed super optimal broth with 
catabolite repression (SOC) medium was added to each tube and the cells were incubated at 
37°C for one hour with shaking at 250 rmp. Cells were spun-down using a high-speed centrifuge, 
approximately 300 μL SOC was removed, the cells were resuspended, and plated on LB agar 
plates infused with antibiotics kanamycin and chloramphenicol. The plates were incubated at 37 
°C overnight. 
 Inducement of Expression Host 
A 2 mL LB culture was started for each mutant transformed to BL21-DE3. After approximately 
18 hours, the 2 mL culture was transferred to a 50 mL LB culture and incubated with shaking at 
37 °C for approximately 18 hours. The 50 mL culture was then transferred to a 500 mL culture 
and monitored until the OD600 reached a value of 0.6. At this point, 500 μL 1M IPTG was 
added to induce expression of MfnB. The culture was incubated at 37 °C with shaking for 4 
hours and the solution was spun down, the cells pelleted, and the supernatant discarded. The 
pellets were then resuspended in approximately 15 mL phosphate bufferc and sonicated to lyse 
cells. The solution was then centrifuged at high speed to remove cellular debris. 
Protein Purification 
After cell lysis, large amount of the target protein were present in the supernatant (visualized by 
SDS-PAGE gel); however, there is also a large amount of unimportant cellular proteins. To 
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separate protein of interest, MfnB, affinity chromatography was used. Specifically, because 
MfnB was subcloned to a vector containing a 6-Histidine tag7 (is this a reference?), nickel resin 
was used to bind and purify the target protein. Histidine has two nitrogen atoms in the imidazole 
ring that both have a lone pair of electrons that are capable of coordinating to the iron resin 
forming a complex that allows the tagged protein to be separated from all other cellular proteins. 
The supernatant from cell lysis (approximately 15 mL) was incubated with 5 mL nickel bead 
resin for one hour at room temperature with slow, consistent shaking. After incubation, the resin 
was resuspended and transferred to a filtration column. The resin was allowed to settle and flow 
through was collected. The resin was then washed with approximately 10 mL of three wash 
buffers each with increasing concentration of imidazole (Table 1). The resulting fractions were 
run on an SDS-PAGE gel to determine which fraction contained MfnB. 
Table 1. Composition of buffers used for protein purification. 
 
SDS PAGE Electrophoresis 
 
An SDS-PAGE gel was made using the following reagents 
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All reagents for the running gel were combined saving ammonium persulfate (APS) and 
tetramethylethylenediamine (TEMED) for last. Once APS and TEMED were added, the running 
gel solution was transferred immediately to a gel casting rig. A thin layer of butanol was then 
layered on top of the running gel and it was left to solidify. All reagents for the stacking gel were 
combined except for APS and TEMED. After solidification, the butanol was decanted and the 
gel was rinsed with H2O. The APS and TEMED were added to the stacking solution, the 
solution was transferred immediately to the gel casting rig, a comb was inserted, and the gel 
solidified. After solidification, the gel was transferred to the running chamber and covered with 
1X SDS running buffer. A volume of 10 μL SDS loading buffer was mixed with 10 μL protein 
sample, heated to 90 °C for 10 minutes and loaded to the gel. The gel was run at 100 V for 
approximately one hour and protein was visualized using Coomassie staining. 
Buffer Exchange 
To remove excess imidazole from the protein solution and to get the protein in the correct buffer 
for the kinetic study, buffer exchange was performed. A desalting column was drained, filled 
with extraction bufferc and allowed to drain. A volume of 3 mL of the fraction from purification 
containing the protein, was poured into the column and allowed to drain. A volume of 4 mL 
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extraction buffer was added to the column, allowed to flow through, and collected in a centrifuge 
tube. This process was repeated until the entire volume of protein solution was put through the 
column. The resulting solution was stored at 4 °C until a Bradford assay was performed.  
 
Bradford Assay 
To establish the concentration of purified protein, a Bradford Assay was conducted. A series of 
BSA standards were generated ranging in concentration from 0-1500 µg/mL. A 30 µL aliquot of 
each standard and each unknown protein was combined with 1.5 mL Bradford reagent, mixed 
thoroughly, and allowed to react for 10 minutes. The absorbance of each solution was taken at a 
wavelength of 595 nm. A calibration curve was built from the standards and the unknown protein 
concentrations were calculated accordingly. The protein solutions were aliquoted into 
microcentrifuge tubes and stored at -20 °C for future use. 
Kinetic Analysis 
A kinetic study utilizing UV/vis spectroscopy was conducted to calculate the catalytic activity of 
MfnB mutants. Because, HMF-P, absorbs UV at a wavelength of 280 nm and the substrate, 
Ga3P does not, the change in absorbance at 280 nm was used to track the progress of the 
reaction. A constant amount of enzyme (4 µg) was incubated with varying amounts of substrate 
and allowed to react over a period of 5 minutes at 70°C. This temperature was used because 
enzyme MfnB is a thermostable enzyme as it is isolated from a hyperthermophile. The initial and 
final absorbances from the most linear portion of the curve were recorded for each substrate 
concentration, and the slope of the line, or the rate of the reaction, was calculated. A control 
measurement was taken using just the enzyme and buffer to account for natural instrument 
fluctuations, and the experimental slope was corrected using this measurement. The corrected 
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rate was then converted into units of 1/s by dividing out enzyme concentration and the resulting 
































































Data and Results 
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Kinetic Parameters at °C 
  kcat (s
-1) KM (μM) kcat/ KM (M
-1s-1) 
Wild-type 0.041 ± 0.002 21 ± 4 2.0 × 103  
D25N ND ND ND 
K27R ND ND ND 
K85R ND ND ND 
D151N ND ND ND 
K155A ND ND ND 
S33A ND ND ND 
S6A ND ND ND 
M149A 0.0048289 ± 0.0004 9.0 ± 3.9  5.36 × 102 
S188A 0.066 ± 0.004 18 ± 5 3.6 × 103 
Y83A 0.000192 ± 1.80e-05 19.8 ± 8 9.7 
R217A 0.00204 ± 0.0003 8.2 ± 6.2 2.49 × 102 
Δ216-218 0.000166 ± 8.03e-06 3.9 ± 1.1  42.6 
Table 2. Results of the kinetic study comparing catalytic activity of wild type MfnB to mutant 
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Of the 14 amino acid residues that were initially identified as strictly or highly conserved, 
a total of 12 mutants were successfully generated and the activities determined. After completion 
of the kinetic study, each of the twelve mutants was sorted into three categories: no activity, 
limited activity, and increased activity (Table 3).  
Table 3. Summary of activities of mutant enzymes with respect to wild type activity.  
Because the amino acid residues chosen for mutation were strictly or highly conserved, it 
was hypothesized that by changing the residue, the enzyme would lose most, or all, function. 
This assertion assumes that the consistency of an amino acid through the evolutionary history 
means that the residue is important to enzyme function and changing the amino acid results in a 
non-functional enzyme which would be detrimental to the organism allowing natural selection to 
occur within the population. Using this logic, the one mutant with increased activity was a 
surprising result. Upon examination of the active site structure of MfnB, the mutated residue 
resulting in increased activity appears to interact with a phosphate molecule in Ga-3P 
(previously, you used Ga3P) binding site I where a phosphate elimination reaction occurs. It is 
hypothesized that changing the amino acid serine to something much smaller, such as alanine, 
encourages the release of phosphate increasing the efficiency of the enzyme; however, further 
testing will be needed to support or refute this claim.  
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With a total of twelve mutants generated and characterized, the focus of the project now 
shifts to the mutants which fall into the category of limited or no activity. The next step is a 
collaboration with a protein crystallographer in hopes of trapping the substrate in the active site 
of the enzyme. Currently, using the wild type enzyme, the catalytic intermediates cannot be 
crystallized due to the fast catalytic activity. The limited and no catalytic activity mutants 
hopefully alleviate this problem making it possible to crystalize the enzyme in a way to capture a 
crystal structure of the amino acid residues interacting with the catalytic intermediate. This 
structure will give insight to the detailed mechanism of MfnB as it will give a clear picture of 
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As a result of this study, a total of 12 mutant enzymes were generated and characterized 
using a site-directed mutagenesis approach paired with a kinetic analysis. Of these 12 mutants, 7 
were determined to have no activity, 4 were determined to have limited activity, and one mutant 
was determined to have an increased activity. These results are promising as the limited activity 
and no activity mutants indicate which amino acids appear to be most important to the enzymatic 
mechanism. Because 11mutants resulted in limited or no catalytic activity, they are good 
candidates for crystallographic studies. Moving forward, a crystallography experiment will be 
conducted using one of the limited or no activity mutants. Once crystallographic studies are 
conducted, there will be a much better understanding of the active site dynamics for MfnB, and a 
detailed mechanism can be generated where specific amino acids are catalytically responsible for 
each reaction step.  
 Furthermore, a well-developed understanding of enzyme MfnB will allow it to be better 
utilized in industry. Ultimately, MfnB can be paired with the first four enzymes of glycolysis to 
construct an in vitro pathway where glucose, a readily available feedstock from biomass, can be 
converted directly to 4,HMF-P using a single-pot synthesis. The efficient biochemical production 
of a valuable chemical in a single process has exciting implications for the biorefinery industry.  
As an added value, because this research was conducted at a teaching institute, it was 
developed to be accessible to undergraduate students. The process of mutant generation and 
characterization through site-directed mutagenesis and kinetic analysis was refined over many 
iterations throughout the past two years. Ultimately, this project has been transformed into an 
upper-level laboratory course designed specifically to give undergraduate students an in-depth 
experience with the scientific research process. As the project is highly interdisciplinary in that is 
requires students to utilize techniques drawn from genetics, organic chemistry, biochemistry, and 
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microbiology, students develop critical thinking and logical analysis skills that are crucial to a 
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Mutation Primer Sequence Tm Restriction 
Enzyme 
S6  A Sense: GAAGAAGCGAAAGAAGCCATTGCTGGTGG        66 SpeI 
Antisense: AACGTCAATCGGGGcgACtAGtAGGATCA 66 
D25  N Sense: gttAAAAACCCGAAGGAAGGCTCACTGGGT 66 AcII 
Antisense: gttGATAATGTCAGCACCACCAGCAATGGC 66 
K27  R Sense: PHOS-CGATGtacgtaACCCGAAGGAAGGCTCAC                             66 SnaBI
Antisense: 
PHOS-ATAATGTCAGCACCACCAGCAATGGCTTCT              
66 




Y83  A Sense: 





K85  R Sense: 
CCGATTATATCAgAGTaGGCCTGTACGGTGTCA 
65 StuI 
Antisense: CACCAGAAATAGCTGCACCAACGGCC 66 
M149  A Sense: CAGGTTGCGACGTCGCAgctctagaTAC 66 XbaI 
Antisense: CATCGCGCGCGATTTTCGGAACAATCAG     66 
D151  N Sense: ---Phos- GCGACGTCgcaatgCTGaatACCGC    66 Nb.Bsrdl 
Antisense: -phos-AACCTGCATCGCGCGCGATTTTCG   67 
K155  A Sense: CTGGATACCGCaATTgcAGACGGCAAGA 66 Mfel 
Antisense: CATTGCGACGTCGCAACCTGCATCG 66 
S188  A Sense: GCACTGGCTggcgccATTAAAAAGG       65 SfoI 
Antisense: ACATTTCAGGCCGTAACTATGGGCTTCGT        66 
Δ216-218 Sense: AATGGTCGTATCGACCGCGAACTGGT 66  
Antisense: ACCtCCtTTaCAAGCTGCACCACGGA 66  
R217  A 
 
Sense: GTGATgccAACAAcggccgTATCGAC      66 Eagl 
Antisense: CGCCCTTGCAAGCTGCACCACG    67 




Buffer P1 Buffer P2 Buffer N3 Buffer PE 
 50 mM Tris-HCl 
pH 8.0 
 10 mM EDTA 
 100 μg/ml 
RNaseA 
 
 200 mM NaOH 
 1% SDS 
 
 4.2 M Gu-HCl 
(Guanidine 
hydrochloride) 
 0.9 M potassium 
acetate 
 pH 4.8 
 8 mM Tris-HCl 
pH 7.5 
 80% ethanol 
 80 mM NaCl 
 
Table S2. Buffer Compositions from Quiagen MiniPrep Plasmid Purification Kit. 
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